Corvus Pharmaceuticals begins Phase 1b trial of soquelitinib in hidradenitis suppurativa

Corvus Pharmaceuticals announced the initiation of a Phase 1b clinical trial of soquelitinib in patients with hidradenitis suppurativa and has started enrolling patients in the study.

Detected & updated continuously · Source: Nebula